Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07639593 · ClinicalTrials.gov registry record · NA
Trial of CGM Technology in Persons Living With Prediabetes
A NA study, sponsored by Wake Forest University Health Sciences.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07639593 is a NA study that has not yet begun recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 100 participants.
The verdict
NCT07639593, a NA study, has not yet begun recruiting, sponsored by Wake Forest University Health Sciences.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Continuous glucose monitor (CGM) technology has become increasingly prevalent in the population and has the ability to transform care of patients living with prediabetes. While the technology was initially utilized primarily by patients living with type 1 diabetes using insulin pump therapy, it has become more widely used as part of care in patients living with type 1 or 2 diabetes on any kind of insulin therapy.
Interventions
- DEVICE Stelo CGM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-08 |
| Est. Completion | 2027-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07639593
The ClinicalTrials.gov registry entry for NCT07639593 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stelo CGM is the first listed.
NCT07639593 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07639593 about?
NCT07639593 is a clinical study titled "Trial of CGM Technology in Persons Living With Prediabetes". Continuous glucose monitor (CGM) technology has become increasingly prevalent in the population and has the ability to transform care of patients living with prediabetes. While the technology was initially utilized primarily by patients living with type 1 diabetes using insulin pump therapy, it has ...
What is the current status of trial NCT07639593?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-08. Estimated completion is 2027-03.
What interventions are being tested in trial NCT07639593?
The interventions under investigation include: Stelo CGM (DEVICE).
Who is sponsoring clinical trial NCT07639593?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.